Key result
Antenatal management of fetuses with functional heart disease did not significantly improve survival compared to no treatment (53% vs. 79%; p=0.06).
Why the study?
Does antenatal management improve survival in fetuses with functional heart disease compared to no treatment?
Observational (n=51)
Does antenatal management improve survival in fetuses with functional heart disease compared to no treatment?
Absolute Event Rate: 53% vs 79%
p-value: p=0.06
Fetal functional heart disease has diverse etiologies and high mortality, and antenatal treatment in this cohort did not significantly improve survival.
No takes yet. Share an insight, caveat, or question.
Antenatal management should not yet guide care in fetal functional heart disease; leaves open whether randomized trials would show survival benefit.
Boldt et al. (2004) conducted an observational in Functional heart disease (n=51). Antenatal management vs. No antenatal management was evaluated on Survival (p=0.06). Antenatal management of fetuses with functional heart disease did not significantly improve survival compared to no treatment (53% vs. 79%; p=0.06).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: